medigraphic.com
ISSN 0035-0052 (Impreso)

2020, Número 2

<< Anterior Siguiente >>

Rev Mex Pediatr 2020; 87 (2)


Terapia de soporte en bronquiolitis aguda grave en una Unidad de Cuidado Intensivo Pediátrico

Vásquez-Hoyos P, González-Rincón JM, Gallego-Salazar AF, Sánchez-Heredia E, Latorre-Montoya GA

Idioma: Español
Referencias bibliográficas: 54
Paginas: 58-64
Archivo PDF: 264.96 Kb.


RESUMEN

Objetivo: Describir el manejo de pacientes con bronquiolitis en una Unidad de Cuidado Intensivo Pediátrico (UCIP), donde se utilizan las recomendaciones de las guías clínicas basada en evidencia (GPC), en las cuales la terapia de soporte es el tratamiento básico. Material y métodos: Estudio descriptivo de una muestra consecutiva de niños que ingresaron por bronquiolitis aguda y que fueron atendidos en una UCIP entre junio de 2016 y diciembre de 2017. Se recolectó la información demográfica, la condición clínica, factores de riesgo, el manejo médico y la evolución hasta el egreso de los pacientes. Resultados: Se identificaron 150 pacientes que cumplieron los criterios de selección. La mediana de edad fue de cuatro meses (RIQ 2 – 9 meses); el 63.6% fueron hombres. Se observó una reducción del uso de medicamentos en el manejo de la UCIP, respecto al manejo previo. El uso de ventilación mecánica invasiva ocurrió en el 18.2% (n = 27) de los pacientes y cánulas nasales de alto flujo en 76.8%. Se detectó co-infección bacteriana en el 19.3%. Seis pacientes fallecieron (4%). Conclusión: En pacientes con bronquiolitis grave, cuando se adhiere a las GPC se disminuye el uso de medicamentos innecesarios.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014; 134(5): e1474-502.

  2. Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet. 2017; 389(10065): 211-224.

  3. Meissner HC. Viral bronchiolitis in children. N Engl J Med. 2016; 374(1): 62-72.

  4. National Institute for Clinical Excellence. Bronchiolitis: diagnosis and management of bronchiolitis in children. Clinical Guideline 9. London: NICE, 2015.

  5. Friedman JN, Rieder MJ, Walton JM. Bronchiolitis: recommendations for diagnosis monitoring and management of children one to 24 months of age. Can J Pediatr. 2014; 19(9): 1485.

  6. Ministerio de Salud y Protección Social. Guía de Práctica Clínica inicial de la Neumonía en niños y niñas menores de 5 años y bronquiolitis en niños y niñas menores de 2 años. Colombia, Ministerio de Salud y Protección Social; 2014.

  7. Rodríguez CE, Sossa MP. Costo-efectividad de la radiografía de tórax en lactantes con sospecha clínica de bronquiolitis viral en Colombia. Rev Panam Salud Publica. 2011; 29(3): 153-161.

  8. Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med. 2006; 48(4): 441-447.

  9. Pierce HC, Mansbach JM, Fisher ES, Macias CG, Pate BM, Piedra PA et al. Variability of intensive care management for children with bronchiolitis. Hosp Pediatr. 2015; 5(4): 175-184.

  10. Ochoa SC, González DJ. Manejo de la bronquiolitis aguda en atención primaria: análisis de variabilidad e idoneidad (proyecto aBREVIADo). An Pediatr. 2013; 79(3): 167-176.

  11. Ochoa Sangrador C, González de Dios J. Overuse of bronchodilators and steroids in bronchiolitis of different severity. Bronchiolitis-study of variability, appropriateness, and adequacy. Allergol Immunopathol (Madr). 2014; 42(4): 307-315.

  12. Ochoa Sangrador C, González de Dios J. Management of acute bronchiolitis in emergency wards in Spain: Variability and appropriateness analysis (aBREVIADo Project). Eur J Pediatr. 2012; 171(7): 1109-1119.

  13. Mittal V, Darnell C, Walsh B, Mehta A, Badawy M, Morse R et al. Inpatient bronchiolitis guideline implementation and resource utilization. Pediatrics. 2014; 133(3): e730-737.

  14. Essouri S, Baudin F, Chevret L, Vincent M, Emeriaud G, Jouvet P. Variability of care in infants with severe bronchiolitis: less-invasive respiratory management leads to similar outcomes. J Pediatr. 2017; 188: 156-162.

  15. Carroll CL, Faustino EVS, Pinto MG, Sala KA, Canarie MF, Li S et al. A regional cohort study of the treatment of critically ill children with bronchiolitis. J Asthma. 2016; 53(10): 1006-1011.

  16. McCulloh RJ, Smitherman S, Adelsky S, Congdon M, Librizzi J, Koehn K et al. Hospitalist and nonhospitalist adherence to evidence-based quality metrics for bronchiolitis. Hosp Pediatr. 2012; 2: 19-25.

  17. Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics. 2005; 115(4): 878-884.

  18. Carande EJ, Cheung CR, Pollard AJ, Drysdale SB. Change in viral bronchiolitis management in primary care in the UK after the publication of NICE guideline. Thorax. 2018; 73: 674-676.

  19. Librizzi J, McCulloh R, Koehn K, Alverson B. Appropriateness of testing for serious bacterial infection in children hospitalized with bronchiolitis. Hosp Pediatr. 2014; 4(1): 33-38.

  20. Tyler A, Krack P, Bakel LA, O’Hara K, Scudamore D, Topoz I et al. Interventions to reduce over-utilized tests and treatments in bronchiolitis. Pediatrics. 2018; 141(6): e20170485.

  21. Khemani RG, Thomas NJ, Venkatachalam V, Scimeme JP, Berutti T, Schneider JB et al. Comparison of SpO2 to PaO2 based markers of lung disease severity for children with acute lung injury. Crit Care Med. 2012; 40(4): 1309-1316.

  22. Rivas-Juesas C, Rius Peris J, García A, Madramany A, Peris M, Álvarez L et al. A comparison of two clinical scores for bronchiolitis. A multicentre and prospective study conducted in hospitalised infants. Allergol Immunopathol (Madr). 2018; 46(1): 15-23.

  23. Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013; 132(2): e341-348.

  24. Destino L, Weisgerber MC, Soung P, Bakalarski D, Yan K, Rehborg R et al. Validity of respiratory scores in bronchiolitis. Hosp Pediatr. 2012; 2(4): 202-209.

  25. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2013; (6): CD004878.

  26. Gadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014; (6): CD001266.

  27. Farley R, Spurling GK, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under two years of age. Cochrane Database Syst Rev. 2014; (10): CD005189.

  28. Liu F, Ouyang J, Sharma AN, Liu S, Yang B, Xiong W et al. Leukotriene inhibitors for bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2015; (3): CD010636.

  29. Li L, Avery R, Budev M, Mossad S, Danziger-Isakov L. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation. J Hear Lung Transplant. 2012; 31(8): 839-844.

  30. Sakulchit T, Goldman R. Nebulized epinephrine for young children with bronchiolitis. Can Fam Physician. 2016; 62: 991-993.

  31. Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2018; (6): CD003123.

  32. Angoulvant F, Bellêttre X, Milcent K, Teglas JP, Claudet I, Le Guen CG et al. Effect of nebulized hypertonic saline treatment in emergency departments on the hospitalization rate for acute bronchiolitis: A randomized clinical trial. JAMA Pediatr. 2017; 171(8): 1-8.

  33. Brooks CG, Harrison WN, Ralston SL. Association between hypertonic saline and hospital length of stay in acute viral bronchiolitis: a reanalysis of 2 meta-analyses. JAMA Pediatr. 2016; 170(6): 577-584.

  34. Maguire C, Cantrill H, Hind D, Bradburn M, Everard M. Hypertonic saline (HS) for acute bronchiolitis: systematic review and meta-analysis. BMC Pulm Med. 2015; 15(1): 1-17.

  35. Kou M, Hwang V, Ramkellawan N. Bronchiolitis: from practice guideline to clinical practice. Emerg Med Clin North Am. 2018; 36: 275-286.

  36. Purcell K, Fergie J. Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2007; 26(4): 311-315.

  37. Ralston SL. Could this be the last word on hypertonic saline? JAMA Pediatr. 2017; 171(8): 7-8.

  38. Oakley E, Borland M, Neutze J, Acworth J, Krieser D, Dalziel S et al. Nasogastric hydration versus intravenous hydration for infants with bronchiolitis: a randomized trial. Lancet Respir Med. 2013; 1(2): 113-120.

  39. Kennedy N, Flanagan N. Is nasogastric fluid therapy a safe alternative to intravenous route in infants with bronchiolitis? Arch Dis Child. 2005; 90: 320-321.

  40. Ross PA, Newth CJ, Khemani RG. Accuracy of pulse oximetry in children. Pediatrics. 2014; 133(1): 22-29.

  41. Quinonez RA, Coon ER, Schroeder AR, Moyer VA. When technology creates uncertainty: pulse oximetry and overdiagnosis of hypoxaemia in bronchiolitis. BMJ. 2017; 358: 1-5.

  42. Vincent JO, Lo H, Wu S. Bronchiolitis care in the hospital. Rev Recent Clin Trials. 2017; 12(4): 1-8.

  43. Sinha IP, McBride AK, Smith R, Fernandes RM. CPAP and high-flow nasal cannula oxygen in bronchiolitis. Chest. 2015; 148(3): 810-823.

  44. Franklin D, Babl FE, Schlapbach LJ, Oakley E, Craig S, Neutze J et al. A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. N Engl J Med. 2018; 378(12): 1121-1131.

  45. Kepreotes E, Whitehead B, Attia J, Oldmeadow C, Collison A, Searles A et al. High-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomized controlled trial. Lancet. 2017; 389 (10072): 930-939.

  46. Ten Brink F, Duke T, Evans J. High-flow nasal prong oxygen therapy or nasopharyngeal continuous positive airway pressure for children with moderate to severe respiratory distress? Pediatr Crit Care Med. 2013; 14(7): e326-331.

  47. Bressan S, Balzani M, Krauss B, Pettenazzo A, Zanconato S, Baraldi E. High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study. Eur J Pediatr. 2013; 172(12): 1649-1656.

  48. McKiernan C, Chua LC, Visintainer PF, Allen H. High flow nasal cannulae therapy in infants with bronchiolitis. J Pediatr. 2010; 156(4): 634-638.

  49. Mayfield S, Bogossian F, O’Malley L, Schibler A. High-flow nasal cannula oxygen therapy for infants with bronchiolitis: pilot study. J Paediatr Child Health. 2014; 50(5): 373-378.

  50. Fretzayas A, Moustaki M. Etiology and clinical features of viral bronchiolitis in infancy. World J Pediatr. 2017; 13(4): 293-299.

  51. Cahill AA, Cohen J. Improving evidence based bronchiolitis care. Clin Pediatr Emerg Med. 2018; 19(1): 33-39.

  52. Thorburn K, Harigopal S, Reddy V, Taylor N, Van Saene HKF. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax. 2006; 61(7): 611-615.

  53. Wiegers HMG, van Nijen L, van Woensel JBM, Bem RA, de Jong MD, Calis JCJ. Bacterial co-infection of the respiratory tract in ventilated children with bronchiolitis; a retrospective cohort study. BMC Infect Dis. 2019;19(1):938.

  54. Ghazaly M, Nadel S. Characteristics of children admitted to intensive care with acute bronchiolitis. Eur J Pediatr. 2018;177(6):913-20.




2020     |     www.medigraphic.com